Back to results
US 2014/0178372 A1Published application
Methods of treating hematologic cancers
AssigneeBioCryst Pharmaceuticals, Inc.
InventorsShanta BANTIA, Philip BREITFELD, Yarlagadda S. BABU
Life of this patent
Estimating the term…
Abstract
The present application relates to treatment of hematologic cancers, which treatments can include, e.g., administration of a purine nucleoside phosphorylase (PNP) inhibitor, an alkylating agent and/or an anti-CD20 agent, and related compositions and kits.
Claims24
A method of treating a hematologic cancer in a subject comprising the steps of:
- a. administering to the subject an effective amount of a purine nucleoside phosphorylase (PNP) inhibitor;
- and
- b. administering to the subject an effective amount of an alkylating agent or an anti-CD20 agent.
A method of treating a hematologic cancer in a subject comprising the steps of:
- a. administering to the subject an effective amount Forodesine;
- and
- b. administering to the subject an effective amount of Rituximab.
A pharmaceutical composition comprising Forodesine and Rituximab.
A kit comprising Forodesine and Rituximab.
Dependencies are inferred from the claim text.